Literature DB >> 6174737

Current therapy for renal cell carcinoma.

M W McDonald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6174737     DOI： 10.1016/s0022-5347(17)53706-4

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  5 in total

1.  Technical points in the ablastic radical removal of tumorous kidneys.

Authors:  J Pintér
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370

2.  Problems of the indications of radiotherapy in renal tumours after radical nephrectomy.

Authors:  M Fehér; J Pintér; V Szokoly
Journal:  Int Urol Nephrol       Date:  1984       Impact factor: 2.370

3.  Clinical studies on cell-mediated immunity in patients with renal cell carcinoma: interleukin-2 and interferon-gamma production of lymphocytes.

Authors:  S Ikemoto; S Wada; M Kamizuru; N Hayahara; T Kishimoto; M Maekawa
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

4.  In vitro antiproliferative efficacy of interferon-alpha, -gamma and tumor necrosis factor on two human renal tumor xenografts.

Authors:  A J Beniers; W P Peelen; B T Hendriks; J A Schalken; J C Romijn; F M Debruyne
Journal:  Urol Res       Date:  1988

5.  Late results of surgical treatment of renal clear-cell carcinoma.

Authors:  M Czaplicki; A Borkowski; S Wesołowski; B Kuzaka; S Walecki; J B Milewski
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.